ArticleOncotarget2017

A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).

Xiaobing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.